Beskrovnaya Oxana
SEC CIK 1824542 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | CSO | 195.8K | — | $3.50M | 31 | 2021-09-20 | 2025-03-11 |
Most active insiders at DYN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rhodes Jason P | Dir | — | $129.10M |
| 2 | Kersten Dirk | Dir | — | $38.57M |
| 3 | Cox John | CEO, Pres, Dir | — | $443.7K |
| 4 | Posner Brian S | Dir | $274.8K | — |
| 5 | Kerr Douglas | Chief Medical Off | — | $233.1K |
| 6 | Lucera Erick | CFO | — | $228.7K |
| 7 | Friedl-Naderer Johanna | Chief Commercial Off | — | $43.4K |
| 8 | Lubner David Charles | Dir | — | — |
Beskrovnaya Oxana made no open-market trades at DYN in the last 12 months.
Transactions 31
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-03-13 | 2025-03-11 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $11.38 | -2,153 | 195.8K | -1% | -$24.5K |
| T | 2025-03-07 | 2025-03-05 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $11.83 | -1,094 | 198.0K | -0.5% | -$12.9K |
| T | 2025-02-25 | 2025-02-18 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $13.95 | -2,598 | 199.1K | -1% | -$36.2K |
| T | 2024-12-11 | 2024-12-11 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $28.12 | -2,334 | 201.7K | -1% | -$65.6K |
| DM | 2024-12-06 | 2024-12-04 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | A - Grant | $0.00 | +66.5K | 204.0K | +48% | $0 |
| T | 2024-11-18 | 2024-11-18 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $28.20 | -2,856 | 137.5K | -2% | -$80.5K |
| T | 2024-09-19 | 2024-09-18 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $34.55 | -2,339 | 140.4K | -2% | -$80.8K |
| T | 2024-09-11 | 2024-09-11 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $31.89 | -2,161 | 142.7K | -1% | -$68.9K |
| MT | 2024-08-20 | 2024-08-19 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $45.12 | -2,636 | 144.9K | -2% | -$118.9K |
| 2024-06-11 | 2024-06-11 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $31.34 | -2,136 | 147.5K | -1% | -$66.9K | |
| DMT | 2024-05-22 | 2024-05-20 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale+OE | $32.96 | -30.4K | 149.6K | -17% | -$1.00M |
| DT | 2024-05-22 | 2024-05-20 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | M - OptEx | $1.03 | +30.4K | 180.1K | +20% | +$31.3K |
| MT | 2024-05-17 | 2024-05-16 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $28.27 | -2,705 | 150.1K | -2% | -$76.5K |
| T | 2024-03-12 | 2024-03-11 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $25.70 | -2,081 | 152.4K | -1% | -$53.5K |
| T | 2024-03-11 | 2024-03-07 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $25.85 | -2,373 | 154.4K | -2% | -$61.3K |
| DMT | 2024-01-04 | 2024-01-03+ | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | M - OptEx | $1.03 | +68.0K | 199.3K | +52% | +$70.0K |
| DMT | 2024-01-04 | 2024-01-03+ | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale+OE | $18.57 | -87.8K | 181.9K | -33% | -$1.63M |
| 2023-12-12 | 2023-12-11 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $10.72 | -1,467 | 176.6K | -0.8% | -$15.7K | |
| D | 2023-11-16 | 2023-11-15 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | A - Grant | $0.00 | +93.7K | 178.1K | +111% | $0 |
| 2023-09-20 | 2023-09-18 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $9.41 | -1,436 | 84.3K | -2% | -$13.5K | |
| 2023-09-13 | 2023-09-12 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $10.41 | -1,484 | 85.8K | -2% | -$15.4K | |
| 2023-06-14 | 2023-06-13 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $12.43 | -1,475 | 87.3K | -2% | -$18.3K | |
| 2023-03-15 | 2023-03-14 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $13.33 | -1,416 | 88.7K | -2% | -$18.9K | |
| D | 2022-12-13 | 2022-12-09 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | A - Grant | $0.00 | +40.0K | 90.8K | +79% | $0 |
| D | 2022-12-13 | 2022-12-12 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $10.87 | -680 | 90.1K | -0.7% | -$7,392 |
| 2022-09-21 | 2022-09-20 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | D - Sale to Iss | $13.70 | -1,413 | 50.8K | -3% | -$19.4K | |
| 2022-09-15 | 2022-09-15 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | D - Sale to Iss | $14.05 | -712 | 52.2K | -1% | -$10.0K | |
| 2022-06-15 | 2022-06-14 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | D - Sale to Iss | $4.95 | -726 | 53.0K | -1% | -$3,594 | |
| 2022-03-14 | 2022-03-11 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $8.73 | -693 | 53.7K | -1% | -$6,050 | |
| D | 2021-12-14 | 2021-12-10 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | A - Grant | $0.00 | +36.5K | 54.4K | +205% | $0 |
| M | 2021-09-22 | 2021-09-20+ | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | CSO | S - Sale | $15.90 | -1,444 | 17.8K | -7% | -$23.0K |
Purchase Sale Sale after option exercise All abbreviations